BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,065 filers reported holding BAXTER INTL INC in Q2 2019. The put-call ratio across all filers is 1.42 and the average weighting 0.3%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $50,308,432 | -22.5% | 1,503,989 | -1.0% | 0.04% | -23.9% |
| Q1 2024 | $64,934,412 | +6.1% | 1,519,289 | -4.1% | 0.05% | +2.2% |
| Q4 2023 | $61,221,551 | -0.2% | 1,583,589 | -2.6% | 0.04% | -6.2% |
| Q3 2023 | $61,368,599 | -26.2% | 1,626,089 | -10.9% | 0.05% | -15.8% |
| Q2 2023 | $83,182,947 | +2.5% | 1,825,789 | -8.7% | 0.06% | +1.8% |
| Q1 2023 | $81,143,890 | -22.2% | 2,000,589 | -2.3% | 0.06% | -25.3% |
| Q4 2022 | $104,324,835 | -11.2% | 2,046,789 | -6.2% | 0.08% | -10.7% |
| Q3 2022 | $117,527,000 | -16.0% | 2,182,075 | +0.1% | 0.08% | -11.6% |
| Q2 2022 | $139,956,000 | -16.8% | 2,178,975 | +0.5% | 0.10% | 0.0% |
| Q1 2022 | $168,151,000 | +3.1% | 2,168,575 | +14.1% | 0.10% | -3.1% |
| Q4 2021 | $163,111,000 | +2.0% | 1,900,175 | -4.4% | 0.10% | -3.9% |
| Q3 2021 | $159,917,000 | -3.6% | 1,988,275 | -3.5% | 0.10% | 0.0% |
| Q2 2021 | $165,804,000 | -20.4% | 2,059,675 | -16.6% | 0.10% | -26.6% |
| Q1 2021 | $208,356,000 | +7.7% | 2,470,425 | +2.4% | 0.14% | +0.7% |
| Q4 2020 | $193,541,000 | -2.6% | 2,412,025 | -2.4% | 0.14% | -11.0% |
| Q3 2020 | $198,647,000 | -8.0% | 2,470,125 | -1.5% | 0.16% | -15.3% |
| Q2 2020 | $216,018,000 | +10.9% | 2,508,925 | +4.6% | 0.18% | -11.6% |
| Q1 2020 | $194,785,000 | +17.4% | 2,399,125 | +20.9% | 0.21% | +21.8% |
| Q4 2019 | $165,921,000 | -7.4% | 1,984,225 | -3.1% | 0.17% | -10.5% |
| Q3 2019 | $179,115,000 | +6.2% | 2,047,725 | -0.6% | 0.19% | +4.4% |
| Q2 2019 | $168,668,000 | -4.5% | 2,059,439 | -5.2% | 0.18% | -6.2% |
| Q1 2019 | $176,625,000 | +26.5% | 2,172,239 | +2.4% | 0.19% | +8.4% |
| Q4 2018 | $139,679,000 | -13.9% | 2,122,139 | +0.8% | 0.18% | -1.1% |
| Q3 2018 | $162,285,000 | +0.3% | 2,105,139 | -3.9% | 0.18% | -2.2% |
| Q2 2018 | $161,816,000 | +20.4% | 2,191,439 | +6.1% | 0.18% | +12.8% |
| Q1 2018 | $134,356,000 | -7.2% | 2,065,739 | -7.8% | 0.16% | +5.1% |
| Q4 2017 | $144,803,000 | +3.9% | 2,240,139 | +0.9% | 0.16% | -1.9% |
| Q3 2017 | $139,345,000 | +5.2% | 2,220,639 | +1.5% | 0.16% | +1.3% |
| Q2 2017 | $132,512,000 | +19.0% | 2,188,839 | +2.0% | 0.16% | +12.9% |
| Q1 2017 | $111,320,000 | +42.9% | 2,146,539 | +22.2% | 0.14% | +13.0% |
| Q4 2016 | $77,889,000 | +19.7% | 1,756,639 | +28.5% | 0.12% | +18.3% |
| Q3 2016 | $65,057,000 | +4.1% | 1,366,739 | -1.1% | 0.10% | +3.0% |
| Q2 2016 | $62,496,000 | +11.7% | 1,382,039 | -2.8% | 0.10% | -1.9% |
| Q1 2016 | $55,952,000 | +48.0% | 1,421,151 | +43.4% | 0.10% | +13.2% |
| Q4 2015 | $37,812,000 | +18.7% | 991,151 | +2.2% | 0.09% | +11.0% |
| Q3 2015 | $31,863,000 | -48.0% | 969,951 | +10.8% | 0.08% | -48.4% |
| Q2 2015 | $61,241,000 | +8.3% | 875,751 | +6.1% | 0.16% | +5.3% |
| Q1 2015 | $56,557,000 | +53.2% | 825,651 | +63.9% | 0.15% | +9.4% |
| Q4 2014 | $36,913,000 | -0.9% | 503,651 | -3.0% | 0.14% | -3.5% |
| Q3 2014 | $37,267,000 | -2.6% | 519,251 | -1.9% | 0.14% | +1.4% |
| Q2 2014 | $38,272,000 | -1.1% | 529,351 | +0.6% | 0.14% | -7.2% |
| Q1 2014 | $38,707,000 | -3.8% | 526,051 | -9.1% | 0.15% | -3.2% |
| Q4 2013 | $40,231,000 | +4.1% | 578,451 | -1.7% | 0.16% | -2.5% |
| Q3 2013 | $38,655,000 | -3.9% | 588,451 | +1.3% | 0.16% | -9.0% |
| Q2 2013 | $40,242,000 | – | 580,951 | – | 0.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Point | 36,000,000 | $2,658,240,000 | 18.52% |
| SECTOR GAMMA AS | 721,058 | $53,243,000 | 8.85% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 2,747,061 | $202,843,000 | 5.38% |
| Veritas Asset Management LLP | 8,852,005 | $653,632,000 | 5.36% |
| Knowledge Leaders Capital, LLC | 79,384 | $5,862,000 | 4.39% |
| HealthCor Management, L.P. | 1,800,000 | $132,912,000 | 4.22% |
| Progressive Investment Management Corp | 79,282 | $5,854,000 | 3.78% |
| 13D Management LLC | 200,318 | $14,791,000 | 3.77% |
| ARGENT CAPITAL MANAGEMENT LLC | 1,288,236 | $95,123,000 | 3.42% |
| Chiron Investment Management, LLC | 612,787 | $45,248,000 | 3.12% |